Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Adult Participants
Clinical trial NCT05133830 · COMPLETED
Trial details
- NCT number
- NCT05133830
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-23
- Primary completion
- 2022-05-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.